The U.S. Food and Drug Administration (FDA) is weighing a change that could make warning labels on dietary supplements appear ...

For decades, the FDA made it nearly impossible to know which factories were manufacturing your generic medications. ProPublica built a tool to show you. Here’s how we did it.

Researchers at Osaka Metropolitan University have discovered a practical way to detect and fix common labeling errors in ...

Based Probiotic Category Ahead of 2026 Weight-Loss Season - Ingredient Research, Regulatory Context, and Evidence Gaps ...

The global protein chip market size is valued at USD 2.36 billion in 2025 and is predicted to hit around USD 4.98 billion by ...

BeOne Medicines ($ONC) announced an update on their ongoing clinical study. BeOne Medicines is running an early-stage trial to test a new cancer ...

AMD Phase 3 timing, Otsuka funding to 2028, and mixed 4D-710 data with financial risk. See why FDMT stock is a hold.

Long-term data published in JAMA Neurology further illustrate the effects of Biogen’s QALSODY on function, strength, and ...

Ceralasertib is an oral selective inhibitor of the ATR kinase, an important DNA-repairing protein in tumor cells.

Explore a probability-driven options framework that bypasses valuation logic to identify favorable risk-reward setups in these large-cap names.

Geron stock struggles as RYTELO faces niche demand, high discontinuation, and major cost cuts. Click here to read my most ...

When you take a drug, where in your body does it actually go? For most medications, scientists can make only educated guesses ...